Author

Tram Nham

Observed names: Nham T, Nham Tram, T. Nham, TRAM NHAM

Institution: RTI Health Solutions

Observed institutions: Harvard University, RTI Health Solutions

ORCID: 0009-0009-3389-2782

Observed ORCID: 0009-0009-3389-2782

OpenAlex ID: A5108986176

Demographics, clinical characteristics, and real-world treatment patterns among patients with beta-thalassemia: a retrospective medical record abstraction study

2024 · Maria Domenica Cappellini, Mrudula B. Glassberg, et al. · Therapeutic Advances in Hematology · 4

Real-world evaluation of PARP inhibitor tolerability in advanced ovarian cancer: Retrospective US cohort study (2209)

2023 · Daniel Simmons, Stephanie Blank, et al. · Gynecologic Oncology · 3

Treatment Patterns, Goals, and Decision-Making Criteria for Second- and Third-Line Therapies for Multiple Myeloma in Germany

2025 · H. Tilman Steinmetz, Franziska Ertel, et al. · Advances in Therapy · 2

Healthcare Resource Utilization and Cost Comparison Between Palbociclib, Abemaciclib, and Ribociclib Among Patients with HR+/HER2− Metastatic Breast Cancer

2025 · Timothy Pluard, Rickard Sandin, et al. · ClinicoEconomics and Outcomes Research · 2

Healthcare resource utilization and costs in patients with eosinophilic granulomatosis with polyangiitis versus severe uncontrolled asthma: a retrospective analysis of US health insurance claims data

2024 · Paul Dolin, Danuta Kielar, et al. · Journal of Allergy and Clinical Immunology · 2

Incidence, Persistence, and Steady‐State Prevalence in Coding Intensity for Health Plan Payment

2025 · Thomas G. McGuire, Oana M. Enache, et al. · Health Services Research · 1

Real-world healthcare resource utilization and cost burden of COVID-19 in commercially insured adults at high-risk of severe disease in the US: a retrospective database analysis

2026 · Tendai Mugwagwa, Benjamin A. Abramoff, et al. · Figshare

Real-world healthcare resource utilization and cost burden of COVID-19 in commercially insured adults at high-risk of severe disease in the US: a retrospective database analysis

2026 · Tendai Mugwagwa, Benjamin A. Abramoff, et al. · Journal of Medical Economics

Healthcare Resource Utilization and Costs for Patients With Eosinophilic Granulomatosis With Polyangiitis in the United States: A Retrospective Analysis of Health Insurance Claims Data

2026 · Paul Dolin, Karina A. Keogh, et al. · medRxiv

Pulmonary and Cardiovascular Involvement and Persistent Damage in Eosinophilic Granulomatosis With Polyangiitis: a Retrospective Analysis of Us Health Insurance Claims Data

2024 · KARINA A KEOGH, PAUL DOLIN, et al. · CHEST Journal

Comorbidities in patients with eosinophilic granulomatosis with polyangiitis and severe uncontrolled asthma: a retrospective analysis of US health insurance claims data

2024 · Paul Dolin, Danuta Kielar, et al. · Journal of Allergy and Clinical Immunology

Study Outcomes Among Patients with Parkinson’s Disease Treated for Psychosis Residing in the Long-Term Care Setting and Newly Initiating Pimavanserin or Off-Label Atypical Antipsychotics

2023 · Juliana Meyers, Tram Nham, et al. · CNS Spectrums

Clinical Burden of β-Thalassemia: Findings from a Multinational Medical Record Abstraction Study

2022 · Maria Domenica Domenica Cappellini, Aylin Yucel, et al. · Blood

P1523: Demographics, Clinical Characteristics, and Real-world Treatment Patterns Among Patients With Beta-thalassemia: a Retrospective Medical Record Abstraction Study

2022 · M. D. Cappellini, A. Yucel, et al. · HemaSphere

Works count: 15

Citation count: 14

H-index: 2

I10-index: